USTR Letter: WTO TRIPS
View letter from PILMA Executive Director, Tim Dickson October 22, 2021Katherine TaiUnited States Trade Representative600 17th Street, NWWashington, DC 20508 Dear Ambassador Tai, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), which advances the dual goals of fostering innovation of life-saving cures and securing high-quality union construction jobs, I write to reiterate […]
Statement on WTO TRIPS Intellectual Property Waiver
On May 6, 2021, PILMA released the following statement on the far reaching negative impacts of the U.S. signing on to the WTO TRIPS waiver. Download the statement here. May 6, 2021 The U.S. Trade Representative’s decision to support waiving intellectual property protections for the COVID-19 vaccine is a danger to worldwide health and security, […]
PILMA 2021 Statement on H.R. 3
On April 23, 2021, PILMA released the following statement in opposition to H.R. 3, the recently announced drug pricing proposal. Download the statement here. April 23, 2021 The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition of biopharmaceutical companies and skilled construction labor unions, reiterate our grave concerns with H.R. 3, the recently announced drug pricing […]
Rockford Register Star: In Illinois, labor and industry are working to rebuild economy
Click here to view the article on the Rockford Register Star website. April 15, 2021 Don Finn is the business manager for IBEW Local 134. Here in Illinois, labor and industry are working together to build up the economy, create jobs and spur innovation. Before the pandemic, we hosted a training facility tour of IBEW/NECA […]
Labor and Industry Joint Letter to Becerra, Pelosi, and Schumer
On April 9, 2021, top leaders of unions and companies who are members of PILMA sent letters to Majority Leader Schumer, Secretary Becerra, and House Speaker Pelosi on the importance of biopharmaceutical facilities built by highly-skilled labor, the robust union jobs supported by the industry, and policies that support or upend this important partnership. Read […]
USTR Letter: PILMA Supports Protection of Intellectual Property Rights
On March 1, 2021, General President of SMART and PILMA Chairman Joseph Sellers, Jr. sent the following letter to the Acting U.S. Trade Representative Maria L. Pagan urging continued protections of intellectual property: View letter from President Sellers. View letter from PILMA Executive Director Timothy Dickson. March 1, 2021Maria L. PaganActing United States Trade Representative600 […]
Macomb Daily: Investment in high-tech fields will strengthen state’s economy
February 10, 2021 Authored by Jon DeRoo, financial secretary for UA Local 98, Detroit, MI The COVID-19 pandemic has created uncertainty across industries. The men and women of the Michigan building trades know this intimately. Early on during this crisis, the construction industry was shut down entirely as we looked for ways to deal with […]
The Electrical Worker Online: Labor and the COVID-19 Vaccine
View the article on the IBEW website. View the downloadable article summary. January 2021 Edition One year after the first cases of COVID-19 were diagnosed in North America, vaccines from Pfizer, AstraZeneca and Moderna are on the verge of becoming widely available. And while IBEW members are not the scientists creating those vaccines, they have […]
TribLive: Trump’s reference pricing order imports joblessness
Former Pennsylvania Congressman Ron Klink authored the following op-ed published on TribLive: October 8, 2020 Never in the history of the modern world has there been such a desperate need for the pharmaceutical industry to be able to save our world and return all of us to a form of normality. Covid-19 is impacting everyone, […]
President Sellers Comments on CMS Notice of Proposed Rule Making
SMART General President Joseph Sellers, Jr. submitted the following comment on the CMS NPRM noting the potential negative impact of the rule on patient access. Download the comment here. The Honorable Seema VermaAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services Attention: CMS–2482-P Re: Establishing Minimum Standards in Medicaid State Drug Utilization […]